Michael Kemp

8.8k total citations · 2 hit papers
170 papers, 6.7k citations indexed

About

Michael Kemp is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Michael Kemp has authored 170 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Epidemiology, 52 papers in Public Health, Environmental and Occupational Health and 38 papers in Infectious Diseases. Recurrent topics in Michael Kemp's work include Infective Endocarditis Diagnosis and Management (28 papers), Bacterial Identification and Susceptibility Testing (27 papers) and Research on Leishmaniasis Studies (25 papers). Michael Kemp is often cited by papers focused on Infective Endocarditis Diagnosis and Management (28 papers), Bacterial Identification and Susceptibility Testing (27 papers) and Research on Leishmaniasis Studies (25 papers). Michael Kemp collaborates with scholars based in Denmark, United Kingdom and United States. Michael Kemp's co-authors include James Hooper, Andrew J.S. Coats, Stefan D. Anker, Hans‐Dieter Volk, Mathias Rauchhaus, Josef Niebauer, Thor G. Theander, Jens Jørgen Christensen, Philip A. Poole‐Wilson and Ralf R. Schumann and has published in prestigious journals such as The Lancet, Circulation and The Journal of Immunology.

In The Last Decade

Michael Kemp

164 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endotoxin and immune activation in chronic heart failure: a prospective cohort study

1999 686 citations Michael Kemp et al. profile →
Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure

2000 673 citations Michael Kemp, James Hooper et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Kemp Denmark	40	1.8k	1.8k	1.3k	962	846	170	6.7k
Irene Cetin Italy	59	1.1k 0.6×	552 0.3×	2.1k 1.6×	1.3k 1.4×	799 0.9×	324	12.5k
Takeshi Shimazu Japan	49	1.7k 0.9×	438 0.2×	443 0.3×	1.4k 1.5×	1.4k 1.7×	312	7.6k
William Thomas United States	62	988 0.5×	530 0.3×	752 0.6×	1.6k 1.6×	1.6k 1.8×	235	12.4k
Peter Lind Sweden	64	1.7k 0.9×	528 0.3×	669 0.5×	2.1k 2.2×	1.2k 1.5×	354	14.7k
José R. Romero United States	52	3.7k 2.0×	1.8k 1.0×	466 0.4×	637 0.7×	909 1.1×	261	10.1k
Wei Zhou China	37	1.6k 0.9×	476 0.3×	759 0.6×	1.0k 1.0×	380 0.4×	169	6.6k
Michael F. Schneider United States	37	858 0.5×	509 0.3×	523 0.4×	541 0.6×	697 0.8×	95	6.7k
Yvon Berland France	43	582 0.3×	496 0.3×	274 0.2×	1.7k 1.8×	774 0.9×	213	6.2k
Raymond C. Boston United States	44	593 0.3×	676 0.4×	526 0.4×	775 0.8×	1.3k 1.6×	216	8.2k
Jukka Mustonen Finland	42	477 0.3×	1.3k 0.7×	606 0.5×	635 0.7×	686 0.8×	276	8.4k

Countries citing papers authored by Michael Kemp

Since Specialization

Citations

This map shows the geographic impact of Michael Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kemp more than expected).

Fields of papers citing papers by Michael Kemp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kemp. The network helps show where Michael Kemp may publish in the future.

Co-authorship network of co-authors of Michael Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kemp. A scholar is included among the top collaborators of Michael Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kemp. Michael Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dargis, Rimtas, et al.. (2025). Next Generation Sequencing Improves Diagnostic 16S rRNA Amplicon‐Based Microbiota Analyses of Clinical Samples Compared to Sanger Sequencing. Apmis. 133(9). e70067–e70067. 1 indexed citations

Hertz, Frederik Boëtius, Karen Leth Nielsen, Helle Krogh Johansen, et al.. (2025). Genetic Variation in the blaZ Gene Leading to the BORSA Phenotype in Staphylococcus aureus. Antibiotics. 14(5). 449–449.

Rebelo, Ana Rita, Valeria Bortolaia, Pimlapas Leekitcharoenphon, et al.. (2025). One day in Denmark: whole-genome sequence-based analysis of Escherichia coli isolates from clinical settings. Journal of Antimicrobial Chemotherapy. 80(4). 1011–1021.

Kemp, Michael, et al.. (2023). First molecular documented case of a rarely reported parasite: Plasmodium knowlesi infection in Denmark in a traveller returning from Malaysian Borneo. Travel Medicine and Infectious Disease. 53. 102580–102580. 2 indexed citations

Rebelo, Ana Rita, Tobias Ibfelt, Valeria Bortolaia, et al.. (2022). One Day in Denmark: Nationwide point-prevalence survey of human bacterial isolates and comparison of classical and whole-genome sequence-based species identification methods. PLoS ONE. 17(2). e0261999–e0261999. 9 indexed citations

Sydenham, Thomas Vognbjerg, Søren Overballe‐Petersen, Henrik Hasman, et al.. (2019). Complete hybrid genome assembly of clinical multidrug-resistant Bacteroides fragilis isolates enables comprehensive identification of antimicrobial-resistance genes and plasmids. Microbial Genomics. 5(11). 26 indexed citations

Hammerum, Anette M., Ulrik Stenz Justesen, Mette Pinholt, et al.. (2019). Surveillance of vancomycin-resistant enterococci reveals shift in dominating clones and national spread of a vancomycin-variable vanA Enterococcus faecium ST1421-CT1134 clone, Denmark, 2015 to March 2019. Eurosurveillance. 24(34). 49 indexed citations

Kemp, Michael, et al.. (2019). 207 An atypical cause of longitudinally extensive transverse myelitis after an allogeneic haemopoietic stem cell transplant. Journal of Neurology Neurosurgery & Psychiatry. 90(12). e52.2–e52.

Jensen, Anne K., Jonas T. Björkman, Steen Ethelberg, et al.. (2016). Molecular Typing and Epidemiology of Human Listeriosis Cases, Denmark, 2002–20121. Emerging infectious diseases. 22(4). 625–633. 60 indexed citations

10.

Kemp, Michael, Rimtas Dargis, Keld Andresen, & Jens Jørgen Christensen. (2012). A Program Against Bacterial Bioterrorism: Improved Patient Management and Acquisition of New Knowledge on Infectious Diseases. Biosecurity and Bioterrorism Biodefense Strategy Practice and Science. 10(2). 203–207.

11.

Hartmeyer, Gitte Nyvang, Anne K. Jensen, S. Böcher, et al.. (2010). Mass spectrometry: Pneumococcal meningitis verified and Brucella species identified in less than half an hour. Scandinavian Journal of Infectious Diseases. 42(9). 716–718. 33 indexed citations

12.

Kemp, Michael, et al.. (2010). Infective Endocarditis: Identification of Catalase-Negative, Gram-Positive Cocci from Blood Cultures by Partial 16S rRNA Gene Analysis and by Vitek 2 Examination. The Open Microbiology Journal. 4(1). 116–122. 5 indexed citations

13.

Wilson, Duncan, T. G. MERRETT, E.‐M. Varga, et al.. (2002). Increases in Allergen-Specific IgE in BAL after Segmental Allergen Challenge in Atopic Asthmatics. American Journal of Respiratory and Critical Care Medicine. 165(1). 22–26. 72 indexed citations

14.

Sear, John W., et al.. (2000). Increases in serum concentrations of cardiac proteins and the prediction of early postoperative cardiovascular complications in noncardiac surgery patients. Anaesthesia. 55(7). 641–647. 34 indexed citations

15.

Yung, Betty, Michael Kemp, James Hooper, & Mark E. Hodson. (1999). Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria. Thorax. 54(1). 40–43. 30 indexed citations

16.

Kemp, Michael, Emanuela Handman, Kåre Kemp, et al.. (1998). TheLeishmaniapromastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity toL. major. FEMS Immunology & Medical Microbiology. 20(3). 209–218. 27 indexed citations

17.

Kemp, Michael. (1998). The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major. FEMS Immunology & Medical Microbiology. 20(3). 209–218. 5 indexed citations

18.

Kemp, Michael, et al.. (1996). Ischaemic preconditioning reduces troponin-T release in patients undergoing cardiac surgery. UCL Discovery (University College London). 1 indexed citations

19.

Taggart, David P., et al.. (1996). Effects of short-term supplementation with coenzyme Q10 on myocardial protection during cardiac operations. The Annals of Thoracic Surgery. 61(3). 829–833. 28 indexed citations

20.

Kemp, Michael, Jørgen A. L. Kurtzhals, Arsalan Kharazmi, & Thor G. Theander. (1993). Interferon‐gamma and interleukin‐4 in human Leishmania donovani infections. Immunology and Cell Biology. 71(6). 583–587. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact